Axio BioPharma is a Contract Development and Manufacturing Organization (CDMO) transforming biopharmaceutical manufacturing. We accelerate the development of mammalian-expressed recombinant proteins, with a focus on monoclonal antibodies (mAbs). Our approach significantly reduces the timeline from lab research to clinical manufacturing, enabling faster delivery of critical therapies. At Axio BioPharma, we are committed to reducing the time it takes to get life-saving therapies to patients.
- Office Locations
- 504 S Rosa Road, STE 200 Madison, WI 53719
- Contact Information
-
Justin Byers
Founder & CEO
[email protected]
Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.
Latest
Journalists and Bloggers
The news you need, when you need it.
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.
LEARN MORE